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SiR.-In 1977, a project of the programme
on clinical oncology of the UICC published a
system ofguide-lines recommended for use in
clinical trials designed to assess the objective
response of locally advanced or metastatic
mammary cancer to treatment (Hayward et
al., 1977). Since then it has become apparent
that the rules for defining duration of remis-
sion are not entirely clear. In particular,
patients achieving a complete objective re-
gression may have, additionally, a period
when only in partial regression. The following
amendments to the original publications have
been agreed.
Categories of response
Objective regression.-(i) Complete response.
The disappearance of all lesions determined
by 2 observations not less than 4 weeks apart.
(ii) Partial response. 50% or more decrease
in measurable lesions, and unequivocal im-
provement in evaluable but non-measurable
lesions, with no new lesions developing; de-
termined by 2 observations not less than 4
weeks apart.
No change and progressive disease.-These
categories remain as defined previously.
Duration of response
It is recommended that: (1) The period of
overall response be from the date of start of
treatment to the date of first observation of
progressive disease.
(2) The period of complete response be from
the date complete response was first recorded
to the date of first observation of progressive
disease.
(3) In those patients who just achieve a
partial response, only the period of overall
response should be recorded.
Thus, in patients achieving a complete ob-
jective remissionthe duration ofthis complete
response should be distinguished from the
longer overall, response recorded in these
cases.
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